|
BioSignia’s flagship technology, Synthesis Analysis, takes
a multi-dimensional approach to predicting the risk of
chronic disease onset, disease progression and mortality
in order to effectively address the needs of diverse
populations.
Synthesis Analysis is a new method for developing
multivariate, predictive equations and was designed to
combine results from hundreds of scientific studies
worldwide. It enables predictive equations to be
constantly updated to reflect the latest research findings
regarding chronic disease risk factors.
As a result, professionals engaged in chronic disease
prevention and management can effectively incorporate new
genomic, proteomic and biochemical discoveries into
existing health risk assessment (HRA) and underwriting
tools. Synthesis Analysis is the “evergreen” engine that
drives BioSignia’s solutions.
|
